Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin chemoprevention after hospital discharge in children with severe anaemia
PACTR202303630742194Phase 3Not yet recruiting
- Sponsor
- Training and Research Unit of Excellence
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in malaria, diarrhea and Airways Infection comparing Azithromycin with Azithromycin placebo (2 arms). Primary endpoint: Non-malaria sick-child clinic visits by 26 weeks from randomization. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
malariadiarrheaAirways Infection
Beyond the preview
Go deeper on PACTR202303630742194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202303630742194.